GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 8 [WO2016138479] | CT179
Compound class:
Synthetic organic
Comment: CT-179 is a brain-penetrant, orally bioavailable OLIG2 (oligodendrocyte transcription factor 2) inhibitor. It has shown efficacy in targeting OLIG2+ve medulloblastoma stem cells in vitro and in vivo [2-3]. It is one of the OLIG2 inhibitor compounds claimed in Curtana Pharmaceuticals patent WO2016138479A1 [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 1-(3,4-dichlorophenyl)-3-[4-[3-(dimethylamino)propylamino]-6-methylpyrimidin-2-yl]urea |
Synonyms ![]() |
| compound 8 [WO2016138479] | CT179 |
Database Links ![]() |
|
| CAS Registry No. | 1996636-69-1 (source: PubChem) |
| ChEBI | CHEBI:234076 |
| DrugBank Ligand | DB17114 |
| GtoPdb PubChem SID | 521588892 |
| PubChem CID | 122520266 |
| Search Google for chemical match using the InChIKey | MWEZWAONAIZIAQ-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | MWEZWAONAIZIAQ |
| UniChem Compound Search for chemical match using the InChIKey | MWEZWAONAIZIAQ-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MWEZWAONAIZIAQ-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖